Chromomycosis and phaeomycotic abscess

AB1_CHROMOMYCOCIS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — B43 Hospital discharge: ICD-9 — 1172 Hospital discharge: ICD-8 — 1172 Cause of death: ICD-10 — B43 Cause of death: ICD-9 — 1172 Cause of death: ICD-8 — 1172 2 out of 7 registries used, show all original rules.	48
4. Check minimum number of events None	48
5. Include endpoints None	48
6. Filter based on genotype QC (FinnGen only)	48

Control definitions (FinnGen only)

Control exclude: AB1_MYCOSES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5

NAME	AB1_CHROMOMYCOCIS
CONTROL_EXCLUDE	AB1_MYCOSES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B43
HD_ICD_9	1172
HD_ICD_8	1172
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B43
COD_ICD_9	1172
COD_ICD_8	1172
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Chromomycosis and phaeomycotic abscess based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	401	184	215
Only index persons	371	174	197
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	38.92	40.77	36.92
Only index persons	38.71	40.88	36.78

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	48	30	18
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	46.32	41.24	54.79

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(42870588) Differential panel, method unspecified - Blood

123

3.15

3.71

13.0

6.8

—

(36304419) Bacteria [Presence] in Urine

107

2.95

3.24

3.0

2.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3.39

3.22

3.6

2.9

0.8

2.6

e6/l

—

(3030467) Casts [#/volume] in Urine by Automated count

106

2.74

2.82

3.2

2.7

0.2

0.3

e6/l

0.12

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3.00

2.67

3.0

2.7

0.7

0.9

e6/l

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3.25

2.37

8.1

5.7

230.1

243.7

u/l

—

(3002582) Erythrocytes [#/volume] in Urine

124

2.43

2.27

3.6

2.7

18.0

27.4

e6/l

0.46

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

4.12

2.24

10.0

6.2

—

(3002256) Pathology report gross observation

2.95

2.19

1.6

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

3.22

2.13

2.2

1.7

—

(40758558) Short blood count panel - Blood

103

2.40

2.11

9.6

6.6

—

(3018095) Leukocytes [#/volume] in Urine

146

2.29

2.04

4.8

3.1

116.5

35.1

e6/l

0.52

103

(3000492) Spirometry study

3.22

1.96

1.6

1.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3.88

1.90

11.7

8.9

24.5

25.3

mmol/l

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.82

1.90

1.5

2.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

116

2.24

1.87

4.9

3.0

25.1

31.5

u/l

1.27

109

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.00

1.82

0.0

7.2

—

(3023368) Bacteria identified in Blood by Culture

2.34

1.79

6.1

4.2

—

(3033658) Prothrombin time (PT) actual/Normal

2.23

1.67

7.6

3.8

96.4

90.2

0.62

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.61

1.66

1.3

1.9

—

(3022145) Colonoscopy Study observation

2.68

1.56

1.2

1.3

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

159

2.02

1.54

8.6

7.1

1.2

mmol/l

0.59

145

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3.36

1.47

1.2

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2.08

1.44

2.3

2.1

—

(3021589) Normoblasts [#/volume] in Blood

181

1.95

1.42

13.7

9.1

0.0

e9/l

0.48

147

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

146

0.46

1.33

2.6

4.0

—

(3042936) Bacteria identified in Isolate by Culture

2.31

1.33

1.7

1.8

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2.81

1.25

13.6

9.8

94.6

94.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.81

1.25

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2.20

1.19

3.7

1.6

377.3

383.7

nmol/l

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2.67

1.18

13.4

9.4

0.4

0.8

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2.67

1.18

13.6

9.4

0.9

1.6

—

(3032080) INR in Blood by Coagulation assay

134

1.84

1.17

6.8

6.4

1.3

1.2

inr

—

(3000991) Gas panel - Venous blood

2.39

1.13

12.4

8.9

—

(3002385) Erythrocyte distribution width [Ratio]

355

2.06

1.08

27.0

14.8

13.7

13.5

0.58

348

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.08

1.06

1.6

2.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

307

1.90

1.01

10.6

7.3

96.6

83.3

u/l

0.24

284

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

206

1.71

0.98

11.6

6.7

11.0

10.8

umol/l

0.06

190

(3024561) Albumin [Mass/volume] in Serum or Plasma

150

1.71

0.96

6.5

4.8

36.6

36.4

g/l

0.07

144

(3044640) Blood type and Crossmatch panel - Blood

123

1.74

0.96

5.9

2.1

—

(4035726)

2.22

0.93

1.7

1.2

—

(40768797) Stomach Pathology biopsy report

1.98

0.91

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.82

0.0

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.82

0.0

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.82

0.0

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.82

0.0

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.82

0.0

1.5

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

140

1.59

0.74

3.8

3.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.03

0.73

2.6

12.7

25.0

24.8

mmol/l

—

(3041096) Erythrocytes [Presence] in Urine by Automated

104

0.52

0.72

2.7

3.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1.95

0.70

2.8

5.1

1.3

1.2

mmol/l

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.72

0.65

2.6

1.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.74

0.63

2.8

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1.74

0.63

1.0

1.3

—

163.9

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.62

0.0

1.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

0.00

0.62

0.0

1.7

—

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

0.00

0.62

0.0

1.7

—

0.2

—

(40761511) CBC panel - Blood by Automated count

426

0.63

0.61

14.6

11.0

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.61

0.0

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.61

0.0

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.61

0.0

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.00

0.60

0.0

2.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

131

1.46

0.52

2.1

1.8

104.5

95.9

pmol/l

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

397

1.80

0.51

18.2

12.8

23.8

23.3

mg/l

0.03

299

(3019550) Sodium [Moles/volume] in Serum or Plasma

400

1.72

0.51

19.4

13.7

140.0

139.7

mmol/l

0.39

386

(3023103) Potassium [Moles/volume] in Serum or Plasma

400

1.72

0.51

19.8

13.7

3.9

mmol/l

0.00

387

(3011397) Hemoglobin [Presence] in Urine by Test strip

1.51

0.50

2.4

3.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

280

1.43

0.48

3.8

3.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.63

0.44

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.42

0.0

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.42

0.0

1.5

—

(3020891) Body temperature

0.00

0.42

0.0

5.3

—

(1002224) Polysomnography panel

0.00

0.41

0.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

0.00

0.41

0.0

1.7

—

136.0

—

(3002032) Base excess in Venous blood by calculation

1.48

0.40

4.0

8.5

-1.2

1.8

mmol/l

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.43

0.39

1.8

2.9

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

106

0.71

0.33

1.5

2.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

372

1.45

0.33

4.8

4.1

4.7

4.6

mmol/l

0.13

354

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

118

0.71

0.32

2.2

63.4

56.7

u/l

—

106

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.67

0.26

1.0

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

193

1.26

0.26

8.0

4.0

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1.39

0.24

4.0

8.2

5.1

5.8

kpa

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.35

0.24

2.0

1.9

—

(3013512) EKG study

101

0.75

0.24

3.4

2.9

—

(3000494) Fungus identified in Specimen by Culture

1.31

0.24

1.4

—

(3015736) pH of Urine

143

0.79

0.22

2.4

3.5

—

(40768804) Tissue Pathology biopsy report

147

1.24

0.22

2.2

1.9

—

(3018405) Lactate [Moles/volume] in Arterial blood

0.00

0.21

0.0

3.9

—

1.0

—

(4034850)

0.00

0.21

0.0

5.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

0.21

0.0

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

(40768793) Breast Pathology biopsy report

0.00

0.21

0.0

1.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1.32

0.21

1.2

2.7

40.0

26.9

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.21

0.0

1.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1.29

0.21

1.3

2.6

1.9

2.4

g/l

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

0.20

0.0

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.20

0.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.20

0.0

1.3

—

(40768443) Skin Pathology biopsy report

0.00

0.20

0.0

1.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1.18

0.20

1.3

2.6

18.1

15.6

umol/l

—

(3048689) Calprotectin [Mass/mass] in Stool

1.22

0.19

3.3

2.3

41.3

83.8

ug/g

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

238

1.20

0.19

8.7

4.9

6.5

6.6

mmol/l

0.03

218

(3037467) Urinalysis macro (dipstick) panel - Urine

281

0.84

0.18

5.4

3.9

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

271

0.84

0.18

3.7

2.9

40.2

44.7

u/l

0.18

254

(3009542) Hematocrit [Volume Fraction] of Blood

374

1.23

0.15

24.4

13.1

39.0

40.1

0.34

291

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.15

0.10

1.4

2.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1.08

0.09

1.2

1.6

741.7

1280.5

nmol/l

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.13

0.08

1.5

2.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

0.86

0.07

2.8

297.1

10375.7

umol/l

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

0.87

0.07

1.3

1.7

—

(3044889) 12 lead EKG panel

258

1.11

0.07

3.9

3.4

—

(1761868) Lipid panel - Serum or Plasma

119

1.13

0.06

1.8

2.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

110

0.89

0.05

1.3

2.0

—

(3026008) Bacteria identified in Urine by Culture

123

1.08

0.02

2.9

2.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1.01

0.00

11.3

6.1

—

(3003694) ABO and Rh group [Type] in Blood

143

0.97

0.00

1.4

1.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

355

1.06

0.00

19.1

10.5

85.1

86.9

ml/min/173m2

0.17

282

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

0.95

0.00

1.2

1.5

456.8

554.0

pmol/l

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

0.92

0.00

6.1

4.7

0.8

1.9

ug/l

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

0.0

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

5.8

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

0.0

2.3

—

4.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

422

1.18

0.00

16.2

10.2

25.7

25.3

u/l

0.06

407

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

0.0

1.5

—

94.1

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.0

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.00

0.0

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

25.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.0

1.9

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.0

1.1

—

(3027315) Oxygen [Partial pressure] in Blood

0.00

0.0

2.8

—

8.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

5.6

—

3205.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

0.00

0.0

1.8

—

2.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

0.0

3.8

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

66.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.0

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

0.0

2.8

—

5.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

7.5

—

178.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.0

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.0

1.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_CHROMOMYCOCIS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have AB1_CHROMOMYCOCIS.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: AB1_CHROMOMYCOCIS – Chromomycosis and phaeomycotic abscess

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Chromomycosis and phaeomycotic abscess

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints